Loading...

Home
ETF
INKT

INKT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

INKT News

MiNK Therapeutics Unveils New Data on iNKT Cell Therapy

Apr 03 2026Newsfilter

MiNK Therapeutics' iNKT Cell Therapy Accepted for ASGCT Presentation

Apr 02 2026Newsfilter

MiNK Therapeutics' iNKT Cell Therapy Accepted for ATS Conference Presentation

Apr 01 2026Newsfilter

MiNK Therapeutics Financial and Clinical Progress Update

Mar 31 2026Yahoo Finance

MiNK Therapeutics Q4 2025 Earnings Call Insights

Mar 31 2026seekingalpha

MiNK Therapeutics Q4 Earnings Beat Expectations

Mar 31 2026seekingalpha

MiNK Therapeutics Announces 2026 Clinical Trial Plans

Mar 31 2026Newsfilter

MiNK Therapeutics Secures $1.1 Million Funding for Pediatric Cancer Collaboration

Mar 10 2026Benzinga

MiNK Therapeutics Partners with C-Further for Pediatric Oncology

Mar 10 2026NASDAQ.COM

MiNK Therapeutics Stock Soars 60% on Key Collaboration with C-Further

Mar 10 2026seekingalpha

MiNK Therapeutics Collaborates with C-Further on Pediatric Cancer Cell Therapy

Mar 10 2026stocktwits

C-Further Advances Pediatric Cancer Therapeutics Initiatives

Mar 10 2026Newsfilter

MiNK Therapeutics Partners with C-Further to Develop Pediatric Cancer Therapy

Mar 10 2026Newsfilter

MiNK Therapeutics Unveils New Insights on iNKT Cells in IPF

Feb 04 2026Newsfilter

MiNK Therapeutics Initiates GvHD Clinical Trial for agenT-797 Therapy

Jan 08 2026Globenewswire

Ryvyl Inc Announces 1-for-35 Reverse Split, Shares Plunge 14.4%

Dec 30 2025Benzinga